U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C31H31N5O2S2.ClH
Molecular Weight 606.201
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SRT-3025 HYDROCHLORIDE

SMILES

Cl.COCCCC1=C(N=C(S1)C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C4=NC5=C(S4)N=CC(CN6CCCC6)=C5

InChI

InChIKey=LGRBDTOIPNDWMN-UHFFFAOYSA-N
InChI=1S/C31H31N5O2S2.ClH/c1-38-17-9-14-26-27(35-29(39-26)22-10-3-2-4-11-22)28(37)33-24-13-6-5-12-23(24)30-34-25-18-21(19-32-31(25)40-30)20-36-15-7-8-16-36;/h2-6,10-13,18-19H,7-9,14-17,20H2,1H3,(H,33,37);1H

HIDE SMILES / InChI
SIRTUIN MODULATOR 1 is a sirtuin modulator developed by Sirtris Pharmaceuticals, Inc. for treating insulin resistance and metabolic syndrome.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
The mass spectrometry assay is conducted as follows: 0.5 μM peptide substrate and 120 μM βNAD+ is incubated with 10 nM SIRTl for 25 minutes at 250C in a reaction buffer (50 mM Tris-acetate pH 8, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 5 mM DTT, 0.05% BSA). SIRTUIN MODULATOR 1 was added to the reaction and after the 25 minute incubation with SIRTl, 10 μL of 10% formic acid is added to stop the reaction. Reactions are sealed and frozen for later mass spec analysis
Name Type Language
SRT-3025 HYDROCHLORIDE
Common Name English
SIRTUIN MODULATOR 1
Preferred Name English
SRT3025 HYDROCHLORIDE
Common Name English
4-THIAZOLECARBOXAMIDE, 5-(3-METHOXYPROPYL)-2-PHENYL-N-(2-(6-(1-PYRROLIDINYLMETHYL)THIAZOLO(5,4-B)PYRIDIN-2-YL)PHENYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
118986647
Created by admin on Wed Apr 02 10:53:21 GMT 2025 , Edited by admin on Wed Apr 02 10:53:21 GMT 2025
PRIMARY
CAS
2070015-26-6
Created by admin on Wed Apr 02 10:53:21 GMT 2025 , Edited by admin on Wed Apr 02 10:53:21 GMT 2025
PRIMARY
FDA UNII
QB3HW37H2A
Created by admin on Wed Apr 02 10:53:21 GMT 2025 , Edited by admin on Wed Apr 02 10:53:21 GMT 2025
PRIMARY